A Long-term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-interventional Post Authorization Study (PAS)
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ADDRESS
- Sponsors Astellas Pharma
- 16 Jan 2018 Status changed from active, no longer recruiting to completed.
- 13 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2017 Interim results (3-year) of the Diamond Study, presented at the 18th Congress of the European Society for Organ Transplantation.